TORSEMIDE

TORSEMIDE was reported 33930 times

These side effects are most commonly reported by patients taking TORSEMIDE:

# Side effect Count
0 DYSPNOEA 3623
1 FATIGUE 2261
2 DIARRHOEA 2144
3 NAUSEA 2119
4 DIZZINESS 2004
5 ACUTE KIDNEY INJURY 1817
6 DEATH 1768
7 GENERAL PHYSICAL HEALTH DETERIORATION 1689
8 FALL 1676
9 OEDEMA PERIPHERAL 1628
10 HEADACHE 1597
11 HYPOTENSION 1545
12 ANAEMIA 1478
13 CARDIAC FAILURE 1403
14 PNEUMONIA 1394
15 COUGH 1369
16 ASTHENIA 1360
17 VOMITING 1312
18 OFF LABEL USE 1220
19 ATRIAL FIBRILLATION 1185
20 PAIN 1155
21 RENAL FAILURE 1118
22 CHRONIC KIDNEY DISEASE 1032
23 CONDITION AGGRAVATED 1029
24 WEIGHT DECREASED 1000
25 DRUG INTERACTION 996
26 DRUG INEFFECTIVE 960
27 PYREXIA 960
28 RENAL IMPAIRMENT 934
29 DEHYDRATION 916
30 FLUID RETENTION 853
31 DECREASED APPETITE 829
32 WEIGHT INCREASED 823
33 ARTHRALGIA 816
34 CARDIAC FAILURE CONGESTIVE 803
35 MALAISE 802
36 PERIPHERAL SWELLING 780
37 PAIN IN EXTREMITY 764
38 CONSTIPATION 752
39 URINARY TRACT INFECTION 740
40 SYNCOPE 726
41 CHEST PAIN 711
42 HYPERTENSION 694
43 PRURITUS 651
44 BLOOD CREATININE INCREASED 640
45 DYSPNOEA EXERTIONAL 633
46 HAEMOGLOBIN DECREASED 617
47 GASTROINTESTINAL HAEMORRHAGE 613
48 HYPOKALAEMIA 603
49 ABDOMINAL PAIN 601
50 PLEURAL EFFUSION 585
51 RASH 569
52 HYPONATRAEMIA 565
53 BACK PAIN 552
54 GAIT DISTURBANCE 539
55 ABDOMINAL PAIN UPPER 532
56 HYPERKALAEMIA 530
57 SEPSIS 525
58 OEDEMA 515
59 EPISTAXIS 503
60 CONFUSIONAL STATE 494
61 HAEMATOCHEZIA 493
62 PRODUCT DOSE OMISSION ISSUE 483
63 SOMNOLENCE 476
64 INSOMNIA 473
65 MYOCARDIAL INFARCTION 465
66 COVID-19 463
67 OXYGEN SATURATION DECREASED 460
68 BRADYCARDIA 453
69 ANXIETY 428
70 BLOOD GLUCOSE INCREASED 428
71 TACHYCARDIA 428
72 FEELING ABNORMAL 427
73 RESPIRATORY FAILURE 424
74 THROMBOCYTOPENIA 424
75 MYALGIA 411
76 ABDOMINAL DISTENSION 410
77 NASOPHARYNGITIS 397
78 BLOOD PRESSURE DECREASED 396
79 PULMONARY HYPERTENSION 396
80 CARDIAC DISORDER 394
81 ABDOMINAL DISCOMFORT 392
82 PALPITATIONS 388
83 MUSCULAR WEAKNESS 386
84 DEPRESSION 382
85 MUSCLE SPASMS 379
86 INFECTION 376
87 BLOOD PRESSURE INCREASED 374
88 HOSPITALISATION 372
89 LOSS OF CONSCIOUSNESS 372
90 PRODUCT PRESCRIBING ERROR 372
91 END STAGE RENAL DISEASE 368
92 RENAL FAILURE ACUTE 359
93 PULMONARY OEDEMA 357
94 PRODUCT USE IN UNAPPROVED INDICATION 355
95 ERYTHEMA 347
96 CHEST DISCOMFORT 342
97 PLATELET COUNT DECREASED 342
98 TREMOR 341
99 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 338
100 HEART RATE INCREASED 333
101 ARRHYTHMIA 332
102 CEREBROVASCULAR ACCIDENT 326
103 GASTROOESOPHAGEAL REFLUX DISEASE 320
104 PULMONARY ARTERIAL HYPERTENSION 315
105 PRODUCT USE ISSUE 314
106 CHILLS 310
107 PRODUCTIVE COUGH 302
108 PRODUCT MONITORING ERROR 295
109 CONTUSION 291
110 DYSPHAGIA 290
111 BRONCHITIS 287
112 CORONARY ARTERY DISEASE 285
113 CARDIAC ARREST 284
114 INCORRECT DOSE ADMINISTERED 280
115 HAEMORRHAGE 279
116 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 279
117 MEMORY IMPAIRMENT 279
118 SYSTEMIC INFECTION 275
119 INFUSION SITE PAIN 273
120 TOXICITY TO VARIOUS AGENTS 271
121 SWELLING 268
122 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 268
123 ASCITES 263
124 BLOOD UREA INCREASED 262
125 ANGINA PECTORIS 258
126 C-REACTIVE PROTEIN INCREASED 258
127 ILLNESS 258
128 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 256
129 DYSURIA 255
130 HYPOAESTHESIA 252
131 BLOOD POTASSIUM INCREASED 244
132 INFLUENZA 243
133 PANCYTOPENIA 241
134 ACUTE RESPIRATORY FAILURE 240
135 DYSPEPSIA 240
136 MELAENA 235
137 PARAESTHESIA 234
138 ELECTROLYTE IMBALANCE 232
139 HYPERGLYCAEMIA 232
140 HYPOGLYCAEMIA 232
141 PERICARDIAL EFFUSION 232
142 THROMBOSIS 232
143 HYPOXIA 231
144 FLUSHING 230
145 BALANCE DISORDER 229
146 FLUID OVERLOAD 229
147 LEUKOPENIA 229
148 DISEASE PROGRESSION 228
149 LACTIC ACIDOSIS 228
150 OROPHARYNGEAL PAIN 228
151 ALANINE AMINOTRANSFERASE INCREASED 225
152 HAEMATOMA 225
153 VISUAL IMPAIRMENT 224
154 PAIN IN JAW 223
155 ASPARTATE AMINOTRANSFERASE INCREASED 222
156 SINUSITIS 220
157 VISION BLURRED 220
158 CELLULITIS 216
159 HYPERHIDROSIS 216
160 MITRAL VALVE INCOMPETENCE 215
161 ALOPECIA 214
162 WHITE BLOOD CELL COUNT DECREASED 213
163 OVERDOSE 212
164 DRY MOUTH 210
165 NEUTROPENIA 210
166 THERAPY NON-RESPONDER 209
167 BLOOD POTASSIUM DECREASED 208
168 DIABETES MELLITUS 208
169 NASAL CONGESTION 208
170 GOUT 205
171 MOBILITY DECREASED 204
172 DRY SKIN 203
173 DRUG HYPERSENSITIVITY 202
174 HAEMATURIA 202
175 CARDIAC FAILURE CHRONIC 201
176 URINARY RETENTION 201
177 DRUG INTOLERANCE 198
178 EJECTION FRACTION DECREASED 198
179 METABOLIC ACIDOSIS 198
180 NEPHROGENIC ANAEMIA 198
181 RESTLESSNESS 195
182 VERTIGO 193
183 PULMONARY EMBOLISM 191
184 GLOMERULAR FILTRATION RATE DECREASED 188
185 HYPERVOLAEMIA 188
186 SEIZURE 188
187 RENAL INJURY 187
188 VENTRICULAR TACHYCARDIA 187
189 ASTHMA 186
190 SEPTIC SHOCK 186
191 TRICUSPID VALVE INCOMPETENCE 185
192 DEPRESSED LEVEL OF CONSCIOUSNESS 184
193 GAMMA-GLUTAMYLTRANSFERASE INCREASED 184
194 MEDICATION ERROR 184
195 LUNG DISORDER 183
196 GASTROINTESTINAL DISORDER 181
197 DISTURBANCE IN ATTENTION 180
198 ELECTROCARDIOGRAM ABNORMAL 180
199 RENAL DISORDER 179
200 WHEEZING 179
201 DEMENTIA 178
202 INTERNATIONAL NORMALISED RATIO INCREASED 178
203 FLATULENCE 177
204 HALLUCINATION 175
205 NEUROPATHY PERIPHERAL 175
206 JOINT SWELLING 173
207 MUSCULOSKELETAL PAIN 173
208 HYPERSENSITIVITY 171
209 THROAT IRRITATION 170
210 DISORIENTATION 169
211 RIGHT VENTRICULAR FAILURE 169
212 OSTEOARTHRITIS 168
213 RHABDOMYOLYSIS 168
214 CARDIAC FAILURE ACUTE 167
215 TACHYPNOEA 167
216 RED BLOOD CELL COUNT DECREASED 166
217 THERAPY INTERRUPTED 166
218 HAEMOPTYSIS 163
219 INFUSION SITE ERYTHEMA 162
220 INJECTION SITE PAIN 160
221 SEASONAL ALLERGY 160
222 UPPER GASTROINTESTINAL HAEMORRHAGE 158
223 ACUTE MYOCARDIAL INFARCTION 157
224 CARDIOGENIC SHOCK 156
225 POLLAKIURIA 154
226 PULMONARY CONGESTION 154
227 UROSEPSIS 154
228 HIATUS HERNIA 153
229 RHINORRHOEA 153
230 PRESYNCOPE 152
231 URTICARIA 152
232 ARTHRITIS 151
233 TREATMENT NONCOMPLIANCE 151
234 DYSPHONIA 150
235 GASTRITIS 150
236 UNEVALUABLE EVENT 150
237 LIVER DISORDER 149
238 SLEEP DISORDER 149
239 ELECTROCARDIOGRAM QT PROLONGED 148
240 HYPERPARATHYROIDISM SECONDARY 148
241 URINARY INCONTINENCE 145
242 CATARACT 143
243 HERPES ZOSTER 143
244 NECK PAIN 143
245 RHEUMATOID ARTHRITIS 143
246 UPPER RESPIRATORY TRACT INFECTION 143
247 GLYCOSYLATED HAEMOGLOBIN INCREASED 142
248 DEEP VEIN THROMBOSIS 141
249 HYPOTHYROIDISM 139
250 IMPAIRED HEALING 138
251 DIVERTICULUM INTESTINAL 137
252 TUBULOINTERSTITIAL NEPHRITIS 135
253 HYPOCALCAEMIA 133
254 LETHARGY 133
255 PALLOR 133
256 BLISTER 132
257 COGNITIVE DISORDER 131
258 DRUG DOSE OMISSION 131
259 DELIRIUM 130
260 HAEMATOCRIT DECREASED 130
261 BLOOD BILIRUBIN INCREASED 129
262 WHITE BLOOD CELL COUNT INCREASED 128
263 MIGRAINE 127
264 BLOOD ALKALINE PHOSPHATASE INCREASED 126
265 CYSTITIS 126
266 HEPATIC STEATOSIS 124
267 POLYNEUROPATHY 124
268 STRESS 124
269 SWELLING FACE 124
270 CONTRAINDICATED PRODUCT ADMINISTERED 123
271 HEPATIC CIRRHOSIS 123
272 OSTEOPOROSIS 123
273 RENAL CYST 123
274 CARDIOVASCULAR DISORDER 122
275 RESPIRATORY TRACT INFECTION 122
276 ATRIAL FLUTTER 121
277 HAEMATEMESIS 121
278 HYPOACUSIS 121
279 PRODUCT DOSE OMISSION 120
280 VENTRICULAR EXTRASYSTOLES 120
281 SKIN ULCER 119
282 DEVICE MALFUNCTION 118
283 PRODUCT ADMINISTRATION ERROR 118
284 AORTIC VALVE INCOMPETENCE 117
285 BLOOD CREATINE PHOSPHOKINASE INCREASED 117
286 BLOOD SODIUM DECREASED 117
287 CARDIOMEGALY 116
288 HAEMORRHOIDS 115
289 HEAD INJURY 115
290 HYPERTENSIVE CRISIS 115
291 IRON DEFICIENCY ANAEMIA 115
292 MALIGNANT NEOPLASM PROGRESSION 115
293 LOCALISED INFECTION 114
294 MUSCULOSKELETAL STIFFNESS 114
295 OBESITY 114
296 PNEUMONIA ASPIRATION 112
297 RALES 112
298 EMOTIONAL DISTRESS 111
299 INTENTIONAL PRODUCT USE ISSUE 111
300 INTERSTITIAL LUNG DISEASE 111
301 TYPE 2 DIABETES MELLITUS 111
302 CARDIOMYOPATHY 110
303 CIRCULATORY COLLAPSE 110
304 DEVICE ISSUE 110
305 PANCREATITIS 110
306 WOUND 110
307 JAUNDICE 109
308 AGITATION 108
309 ARTERIOSCLEROSIS 108
310 BLOOD PRESSURE FLUCTUATION 108
311 LIMB INJURY 108
312 INFUSION SITE SWELLING 107
313 SPINAL OSTEOARTHRITIS 106
314 DEPRESSED MOOD 105
315 GAIT INABILITY 105
316 SKIN DISCOLOURATION 105
317 HEART RATE DECREASED 104
318 HEART RATE IRREGULAR 104
319 HYPERTHYROIDISM 104
320 DIABETES MELLITUS INADEQUATE CONTROL 103
321 DIVERTICULITIS 103
322 RECTAL HAEMORRHAGE 103
323 SKIN EXFOLIATION 103
324 CEREBRAL HAEMORRHAGE 102
325 DYSARTHRIA 102
326 INFLAMMATION 102
327 LEUKOCYTOSIS 102
328 ORTHOSTATIC HYPOTENSION 102
329 POLYURIA 102
330 STAPHYLOCOCCAL INFECTION 101
331 BONE PAIN 100
332 HOT FLUSH 100
333 HYPOTONIA 100
334 RASH PRURITIC 100
335 ATRIOVENTRICULAR BLOCK FIRST DEGREE 99
336 BLOOD GLUCOSE DECREASED 99
337 EXERCISE TOLERANCE DECREASED 99
338 LEFT VENTRICULAR DYSFUNCTION 99
339 ANURIA 98
340 CHOLELITHIASIS 98
341 DEVICE DISLOCATION 98
342 HEPATIC ENZYME INCREASED 98
343 INJURY 98
344 TINNITUS 98
345 ILL-DEFINED DISORDER 97
346 THERAPY CESSATION 97
347 HYPERLIPIDAEMIA 96
348 FEELING HOT 95
349 HEPATIC FAILURE 95
350 STOMATITIS 95
351 EYE PAIN 94
352 LEFT VENTRICULAR HYPERTROPHY 94
353 RENAL FAILURE CHRONIC 94
354 ABDOMINAL PAIN LOWER 93
355 COVID-19 PNEUMONIA 93
356 MUCOSAL INFLAMMATION 93
357 MYELOSUPPRESSION 93
358 TRANSIENT ISCHAEMIC ATTACK 93
359 BENIGN PROSTATIC HYPERPLASIA 92
360 DERMATITIS CONTACT 92
361 HYPERURICAEMIA 92
362 LABORATORY TEST ABNORMAL 92
363 RESTLESS LEGS SYNDROME 92
364 FEBRILE NEUTROPENIA 91
365 PLASMA CELL MYELOMA 91
366 UNDERDOSE 91
367 ADVERSE DRUG REACTION 90
368 GENERALISED OEDEMA 90
369 PROTHROMBIN TIME PROLONGED 90
370 SLEEP APNOEA SYNDROME 90
371 HYPOPHAGIA 89
372 INFLUENZA LIKE ILLNESS 89
373 LOWER GASTROINTESTINAL HAEMORRHAGE 89
374 PANCREATITIS ACUTE 89
375 PROTEINURIA 89
376 ADVERSE EVENT 88
377 SUBDURAL HAEMATOMA 88
378 SURGERY 88
379 AGRANULOCYTOSIS 87
380 AMNESIA 87
381 AORTIC ARTERIOSCLEROSIS 87
382 BRAIN NATRIURETIC PEPTIDE INCREASED 87
383 DIZZINESS POSTURAL 87
384 DYSGEUSIA 87
385 FEMUR FRACTURE 87
386 LIMB DISCOMFORT 87
387 NEOPLASM MALIGNANT 87
388 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 86
389 ARTERIOSCLEROSIS CORONARY ARTERY 86
390 BLOOD URIC ACID INCREASED 85
391 DIASTOLIC DYSFUNCTION 85
392 NEUTROPHIL COUNT DECREASED 85
393 BASAL CELL CARCINOMA 84
394 HYPERSOMNIA 84
395 MULTIPLE ORGAN DYSFUNCTION SYNDROME 84
396 SPINAL STENOSIS 84
397 CLOSTRIDIUM DIFFICILE INFECTION 83
398 ERUCTATION 83
399 LYMPHOCYTE COUNT DECREASED 83
400 NERVOUSNESS 83
401 HIP FRACTURE 82
402 DEVICE LEAKAGE 81
403 DYSSTASIA 81
404 GASTRIC ULCER 81
405 TOXIC EPIDERMAL NECROLYSIS 81
406 UNRESPONSIVE TO STIMULI 81
407 VENTRICULAR FIBRILLATION 81
408 PSORIASIS 80
409 SUICIDE ATTEMPT 80
410 TRANSAMINASES INCREASED 80
411 WEIGHT FLUCTUATION 80
412 CARDIO-RESPIRATORY ARREST 79
413 HYPERCHOLESTEROLAEMIA 79
414 INJECTION SITE ERYTHEMA 79
415 INTERVERTEBRAL DISC PROTRUSION 79
416 MULTI-ORGAN FAILURE 79
417 ORTHOPNOEA 79
418 THIRST 79
419 ATRIOVENTRICULAR BLOCK COMPLETE 78
420 CONJUNCTIVITIS 78
421 HAEMOGLOBIN INCREASED 78
422 PARKINSONISM 78
423 RIB FRACTURE 78
424 SPEECH DISORDER 78
425 DRUG-INDUCED LIVER INJURY 77
426 FEELING COLD 77
427 HYPOVOLAEMIA 77
428 LEFT VENTRICULAR FAILURE 77
429 DYSPNOEA AT REST 76
430 ERYSIPELAS 76
431 LYMPHOEDEMA 76
432 MENTAL STATUS CHANGES 76
433 TACHYARRHYTHMIA 76
434 BLOOD ALBUMIN DECREASED 75
435 BURNING SENSATION 75
436 FAECES DISCOLOURED 75
437 FEAR 75
438 GASTROENTERITIS 75
439 INFUSION SITE HAEMORRHAGE 75
440 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 75
441 NEPHROPATHY 75
442 NOCTURIA 75
443 SPLENOMEGALY 75
444 VASCULAR DEVICE INFECTION 75
445 DEVICE RELATED INFECTION 74
446 HYPOMAGNESAEMIA 74
447 MENTAL DISORDER 74
448 CORONARY ARTERY STENOSIS 73
449 DEAFNESS 73
450 DIALYSIS 73
451 RESPIRATORY DISORDER 73
452 THERAPEUTIC DRUG MONITORING ANALYSIS NOT PERFORMED 73
453 CHOLESTASIS 72
454 DEVICE INFUSION ISSUE 72
455 DISCOMFORT 72
456 ENCEPHALOPATHY 72
457 HEPATOTOXICITY 72
458 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 72
459 NIGHT SWEATS 72
460 PRODUCT QUALITY ISSUE 72
461 ACCIDENTAL OVERDOSE 71
462 AGEUSIA 71
463 APHASIA 71
464 LIVER FUNCTION TEST ABNORMAL 71
465 SINUS TACHYCARDIA 71
466 SKIN DISORDER 71
467 BLOOD LACTATE DEHYDROGENASE INCREASED 70
468 CLOSTRIDIUM DIFFICILE COLITIS 70
469 REBOUND ACID HYPERSECRETION 70
470 SPINAL PAIN 70
471 FAECALOMA 69
472 VIRAL INFECTION 69
473 COAGULOPATHY 68
474 CYANOSIS 68
475 DISEASE RECURRENCE 68
476 DYSKINESIA 68
477 INTENTIONAL OVERDOSE 68
478 INTENTIONAL PRODUCT MISUSE 68
479 TRANSFUSION 68
480 COLITIS 67
481 PRESCRIBED UNDERDOSE 67
482 RESPIRATORY TRACT CONGESTION 67
483 ACTINIC KERATOSIS 66
484 ANGIOEDEMA 66
485 ARTHROPATHY 66
486 HALLUCINATION, VISUAL 66
487 ISCHAEMIC STROKE 66
488 SKIN LESION 66
489 VENTRICULAR ARRHYTHMIA 66
490 BLOOD CHOLESTEROL INCREASED 65
491 CEREBRAL INFARCTION 65
492 COLD SWEAT 65
493 CONCOMITANT DISEASE AGGRAVATED 65
494 DEVICE OCCLUSION 65
495 INTERNAL HAEMORRHAGE 65
496 FULL BLOOD COUNT DECREASED 64
497 FUNGAL INFECTION 64
498 HEPATIC FUNCTION ABNORMAL 64
499 RED CELL DISTRIBUTION WIDTH INCREASED 64
500 SINUS DISORDER 64
501 BLOOD CALCIUM DECREASED 63
502 BLOOD GLUCOSE ABNORMAL 63
503 INJECTION SITE PRURITUS 63
504 NEPHROLITHIASIS 63
505 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 63
506 PERITONITIS 63
507 SINUS BRADYCARDIA 63
508 FLANK PAIN 62
509 LIVER FUNCTION TEST INCREASED 62
510 MOTOR DYSFUNCTION 62
511 RENAL FUNCTION TEST ABNORMAL 62
512 RETCHING 62
513 BLOOD PRESSURE ABNORMAL 61
514 DRUG LEVEL INCREASED 61
515 GASTRITIS EROSIVE 61
516 OLIGURIA 61
517 PNEUMONITIS 61
518 PULMONARY FIBROSIS 61
519 SUPRAVENTRICULAR TACHYCARDIA 61
520 BLOOD PRESSURE SYSTOLIC INCREASED 60
521 HEPATIC CYST 60
522 ILEUS 60
523 INFLAMMATORY MARKER INCREASED 60
524 LYMPHADENOPATHY 60
525 BLINDNESS 59
526 BLOOD CREATINE INCREASED 59
527 COMPLETED SUICIDE 59
528 INFUSION SITE INFECTION 59
529 INITIAL INSOMNIA 59
530 LUNG INFILTRATION 59
531 MOVEMENT DISORDER 59
532 MULTIPLE DRUG THERAPY 59
533 RENAL ARTERY STENOSIS 59
534 SKIN LACERATION 59
535 HERNIA 58
536 INTESTINAL OBSTRUCTION 58
537 JOINT DISLOCATION 58
538 MYELODYSPLASTIC SYNDROME 58
539 SEDATION 58
540 VENTRICULAR HYPOKINESIA 58
541 BLOOD LOSS ANAEMIA 57
542 FOETAL EXPOSURE DURING PREGNANCY 57
543 RASH MACULAR 57
544 TORSADE DE POINTES 57
545 AORTIC DILATATION 56
546 ATRIOVENTRICULAR BLOCK 56
547 CACHEXIA 56
548 COMA 56
549 DRUG DEPENDENCE 56
550 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 56
551 INFUSION RELATED REACTION 56
552 LARGE INTESTINE POLYP 56
553 NEURALGIA 56
554 OBSTRUCTIVE SLEEP APNOEA SYNDROME 56
555 OSTEOCHONDROSIS 56
556 SPINAL FRACTURE 56
557 SUBARACHNOID HAEMORRHAGE 56
558 TROPONIN INCREASED 56
559 BREATH SOUNDS ABNORMAL 55
560 DEVICE FAILURE 55
561 DEVICE USE ERROR 55
562 DYSLIPIDAEMIA 55
563 FRACTURE 55
564 GROIN PAIN 55
565 LIPASE INCREASED 55
566 MUSCLE RIGIDITY 55
567 OSTEOMYELITIS 55
568 QUALITY OF LIFE DECREASED 55
569 RASH ERYTHEMATOUS 55
570 THERAPY PARTIAL RESPONDER 55
571 AORTIC VALVE STENOSIS 54
572 DIPLOPIA 54
573 BLOOD PRESSURE SYSTOLIC DECREASED 53
574 BRADYKINESIA 53
575 CARDIAC PACEMAKER INSERTION 53
576 ECZEMA 53
577 EPILEPSY 53
578 EYE IRRITATION 53
579 HOSPICE CARE 53
580 INJECTION SITE BRUISING 53
581 JOINT INJURY 53
582 SHOCK 53
583 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 53
584 VITAMIN D DEFICIENCY 53
585 ANHEDONIA 52
586 CYTOKINE RELEASE SYNDROME 52
587 DRUG ERUPTION 52
588 DRY EYE 52
589 HYPERVENTILATION 52
590 MOUTH ULCERATION 52
591 RASH MACULO-PAPULAR 52
592 SKIN HAEMORRHAGE 52
593 SPUTUM DISCOLOURED 52
594 SQUAMOUS CELL CARCINOMA OF SKIN 52
595 STEVENS-JOHNSON SYNDROME 52
596 SUICIDAL IDEATION 52
597 THERAPEUTIC RESPONSE UNEXPECTED 52
598 URINE OUTPUT DECREASED 52
599 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 51
600 ESCHERICHIA INFECTION 51
601 HEPATIC ENCEPHALOPATHY 51
602 INTENTIONAL DOSE OMISSION 51
603 TASTE DISORDER 51
604 ALTERED STATE OF CONSCIOUSNESS 50
605 BLOOD IRON DECREASED 50
606 BUNDLE BRANCH BLOCK LEFT 50
607 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 50
608 FACE OEDEMA 50
609 HYPOALBUMINAEMIA 50
610 INFUSION SITE DISCHARGE 50
611 OSTEOPENIA 50
612 RESPIRATORY DISTRESS 50
613 SCIATICA 50
614 DUODENITIS 49
615 EYE SWELLING 49
616 GLOMERULAR FILTRATION RATE ABNORMAL 49
617 INCONTINENCE 49
618 INJECTION SITE HAEMORRHAGE 49
619 IRON DEFICIENCY 49
620 MUSCULOSKELETAL DISCOMFORT 49
621 NO ADVERSE EVENT 49
622 OXYGEN CONSUMPTION INCREASED 49
623 PRODUCT DOSE OMISSION IN ERROR 49
624 ULCER 49
625 ACNE 48
626 ARTERIAL HAEMORRHAGE 48
627 HYPERTENSIVE HEART DISEASE 48
628 LOCALISED OEDEMA 48
629 LOWER LIMB FRACTURE 48
630 MICTURITION URGENCY 48
631 PERIPHERAL VENOUS DISEASE 48
632 ROAD TRAFFIC ACCIDENT 48
633 BLOOD MAGNESIUM DECREASED 47
634 COMPLICATION ASSOCIATED WITH DEVICE 47
635 HAEMORRHOIDAL HAEMORRHAGE 47
636 RENAL TUBULAR NECROSIS 47
637 ACCIDENTAL EXPOSURE TO PRODUCT 46
638 ACUTE CORONARY SYNDROME 46
639 CAROTID ARTERIOSCLEROSIS 46
640 CHRONIC GASTRITIS 46
641 HEMIPARESIS 46
642 INFUSION SITE PRURITUS 46
643 NIGHTMARE 46
644 PREMATURE BABY 46
645 PRESCRIBED OVERDOSE 46
646 SHOCK HAEMORRHAGIC 46
647 BUNDLE BRANCH BLOCK RIGHT 45
648 CATHETERISATION CARDIAC 45
649 CHROMATURIA 45
650 CONGESTIVE CARDIOMYOPATHY 45
651 DRUG ABUSE 45
652 HEPATOMEGALY 45
653 IMMOBILE 45
654 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 45
655 PANIC ATTACK 45
656 POST PROCEDURAL COMPLICATION 45
657 SNEEZING 45
658 SUPRAVENTRICULAR EXTRASYSTOLES 45
659 VENTRICULAR SEPTAL DEFECT 45
660 ATELECTASIS 44
661 CANDIDA INFECTION 44
662 CONVULSION 44
663 DELAYED GRAFT FUNCTION 44
664 DIVERTICULUM 44
665 EAR INFECTION 44
666 GASTROENTERITIS VIRAL 44
667 HEART DISEASE CONGENITAL 44
668 IRRITABILITY 44
669 ISCHAEMIC CARDIOMYOPATHY 44
670 MEAN CELL VOLUME INCREASED 44
671 ORTHOSTATIC INTOLERANCE 44
672 PERIPHERAL CIRCULATORY FAILURE 44
673 PERIPHERAL COLDNESS 44
674 PYELONEPHRITIS 44
675 VARICOSE VEIN 44
676 VASCULITIS 44
677 ABSCESS 43
678 ANXIETY DISORDER 43
679 BACTERAEMIA 43
680 BLOOD COUNT ABNORMAL 43
681 BLOOD TEST ABNORMAL 43
682 CARDIAC AMYLOIDOSIS 43
683 DECUBITUS ULCER 43
684 FLUID INTAKE REDUCED 43
685 INGUINAL HERNIA 43
686 MYOCARDIAL ISCHAEMIA 43
687 MYOPATHY 43
688 OCULAR HYPERAEMIA 43
689 PLATELET COUNT INCREASED 43
690 SKIN CANCER 43
691 BACTERIAL INFECTION 42
692 CATHETER SITE HAEMORRHAGE 42
693 CHOLECYSTITIS 42
694 DEVICE DIFFICULT TO USE 42
695 ESCHERICHIA URINARY TRACT INFECTION 42
696 HAEMODIALYSIS 42
697 HEAD DISCOMFORT 42
698 HYPOTHERMIA 42
699 INTERNATIONAL NORMALISED RATIO ABNORMAL 42
700 LUNG NEOPLASM MALIGNANT 42
701 MALNUTRITION 42
702 APLASTIC ANAEMIA 41
703 ASPIRATION 41
704 BREAST CANCER 41
705 CONGENITAL CARDIOVASCULAR ANOMALY 41
706 DECREASED ACTIVITY 41
707 EYE PRURITUS 41
708 HYPOCHROMIC ANAEMIA 41
709 LIVER INJURY 41
710 MATERNAL EXPOSURE DURING PREGNANCY 41
711 MICTURITION DISORDER 41
712 NEPHROTIC SYNDROME 41
713 PANCREATIC STEATOSIS 41
714 POLYP 41
715 POOR QUALITY SLEEP 41
716 AGGRESSION 40
717 AORTIC STENOSIS 40
718 BRASH SYNDROME 40
719 CORONARY ARTERY OCCLUSION 40
720 DEVICE BREAKAGE 40
721 DRY THROAT 40
722 ECONOMIC PROBLEM 40
723 ENTEROCOCCAL INFECTION 40
724 EXTRA DOSE ADMINISTERED 40
725 FACIAL PAIN 40
726 FEEDING DISORDER 40
727 GASTRIC POLYPS 40
728 HAEMARTHROSIS 40
729 HAEMORRHAGIC ANAEMIA 40
730 HELICOBACTER TEST POSITIVE 40
731 HEPATITIS 40
732 HEPATOSPLENOMEGALY 40
733 LOWER RESPIRATORY TRACT INFECTION 40
734 MUSCULOSKELETAL CHEST PAIN 40
735 STUPOR 40
736 TRUNCUS ARTERIOSUS PERSISTENT 40
737 UPPER LIMB FRACTURE 40
738 ANAPHYLACTIC REACTION 39
739 BLINDNESS TRANSIENT 39
740 BLOOD CHOLESTEROL DECREASED 39
741 BLOOD THYROID STIMULATING HORMONE INCREASED 39
742 CARDIAC MURMUR 39
743 CARDIAC SEPTAL DEFECT 39
744 CARDIAC VALVE DISEASE 39
745 HAEMODYNAMIC INSTABILITY 39
746 HAEMORRHAGE INTRACRANIAL 39
747 HALLUCINATION, AUDITORY 39
748 HYPOKINESIA 39
749 INFUSION SITE INDURATION 39
750 INJECTION SITE SWELLING 39
751 LACRIMATION INCREASED 39
752 METASTASES TO LIVER 39
753 MYOCARDITIS 39
754 POSTOPERATIVE WOUND INFECTION 39
755 RECTAL PROLAPSE 39
756 AZOTAEMIA 38
757 BRADYARRHYTHMIA 38
758 EOSINOPHILIA 38
759 FOOT FRACTURE 38
760 GOITRE 38
761 INFUSION SITE REACTION 38
762 KIDNEY INFECTION 38
763 NEOPLASM PROGRESSION 38
764 OESOPHAGITIS 38
765 WOUND DEHISCENCE 38
766 WOUND INFECTION 38
767 BEDRIDDEN 37
768 BODY TEMPERATURE INCREASED 37
769 DIABETIC FOOT 37
770 GANGRENE 37
771 GASTRIC DISORDER 37
772 LIP SWELLING 37
773 LOW DENSITY LIPOPROTEIN INCREASED 37
774 ORAL HERPES 37
775 PERICARDITIS 37
776 RENAL CYST HAEMORRHAGE 37
777 ROTATOR CUFF SYNDROME 37
778 SECRETION DISCHARGE 37
779 TENDERNESS 37
780 VISUAL ACUITY REDUCED 37
781 ABORTION INDUCED 36
782 APNOEA 36
783 FIBROMYALGIA 36
784 GASTRIC HAEMORRHAGE 36
785 HYPOVOLAEMIC SHOCK 36
786 LOW BIRTH WEIGHT BABY 36
787 PROSTATE CANCER 36
788 SWOLLEN TONGUE 36
789 TOOTH DISORDER 36
790 TUMOUR LYSIS SYNDROME 36
791 VENTRICULAR ENLARGEMENT 36
792 VITAMIN D DECREASED 36
793 BLOOD PRESSURE DIASTOLIC DECREASED 35
794 BLOOD URINE PRESENT 35
795 BURSITIS 35
796 DEVICE CONNECTION ISSUE 35
797 DRUG TOLERANCE DECREASED 35
798 EJECTION FRACTION ABNORMAL 35
799 FREQUENT BOWEL MOVEMENTS 35
800 MUSCLE TWITCHING 35
801 ORAL PAIN 35
802 PARKINSON^S DISEASE 35
803 PETECHIAE 35
804 POST PROCEDURAL HAEMORRHAGE 35
805 PRODUCT USE COMPLAINT 35
806 PROTEIN URINE PRESENT 35
807 SINUS CONGESTION 35
808 BACK DISORDER 34
809 BLOOD TRIGLYCERIDES INCREASED 34
810 ECCHYMOSIS 34
811 EMPHYSEMA 34
812 HYPERCALCAEMIA 34
813 INFUSION SITE IRRITATION 34
814 INSURANCE ISSUE 34
815 LABELLED DRUG-DRUG INTERACTION ISSUE 34
816 ORAL CANDIDIASIS 34
817 PNEUMONIA BACTERIAL 34
818 PNEUMOTHORAX 34
819 PULMONARY ARTERIAL PRESSURE INCREASED 34
820 RASH PAPULAR 34
821 SINUS NODE DYSFUNCTION 34
822 BLOOD POTASSIUM ABNORMAL 33
823 BODY HEIGHT DECREASED 33
824 BRAIN FOG 33
825 CARDIAC DYSFUNCTION 33
826 CARDIOPULMONARY FAILURE 33
827 COMPLICATIONS OF TRANSPLANTED KIDNEY 33
828 CORONAVIRUS INFECTION 33
829 DIABETIC NEUROPATHY 33
830 FEMORAL HERNIA INCARCERATED 33
831 HAEMANGIOMA 33
832 IMPAIRED GASTRIC EMPTYING 33
833 NERVOUS SYSTEM DISORDER 33
834 PAIN OF SKIN 33
835 PARALYSIS 33
836 RESPIRATORY TRACT HAEMORRHAGE 33
837 ANKLE FRACTURE 32
838 ATRIAL TACHYCARDIA 32
839 ATRIAL THROMBOSIS 32
840 FEELING JITTERY 32
841 HEREDITARY ANGIOEDEMA 32
842 LYMPHATIC FISTULA 32
843 MULTIPLE SCLEROSIS 32
844 MYOCLONUS 32
845 OSTEONECROSIS 32
846 PARESIS 32
847 PRODUCT ADMINISTRATION INTERRUPTED 32
848 PRODUCT DISPENSING ERROR 32
849 PRODUCT DISTRIBUTION ISSUE 32
850 PROTEIN TOTAL DECREASED 32
851 SEROMA 32
852 SKIN BURNING SENSATION 32
853 SWELLING OF EYELID 32
854 SYSTEMIC LUPUS ERYTHEMATOSUS 32
855 THERAPEUTIC DRUG MONITORING ANALYSIS INCORRECTLY PERFORMED 32
856 THERAPEUTIC RESPONSE DECREASED 32
857 ACUTE PRERENAL FAILURE 31
858 ATAXIA 31
859 BLOOD CALCIUM INCREASED 31
860 BONE DISORDER 31
861 COLON CANCER 31
862 EAR DISCOMFORT 31
863 FOLATE DEFICIENCY 31
864 GALLBLADDER DISORDER 31
865 GINGIVAL BLEEDING 31
866 HUMERUS FRACTURE 31
867 HYPERBILIRUBINAEMIA 31
868 HYPERPARATHYROIDISM 31
869 INTESTINAL HAEMORRHAGE 31
870 LEFT ATRIAL ENLARGEMENT 31
871 METABOLIC ALKALOSIS 31
872 PHARMACEUTICAL PRODUCT COMPLAINT 31
873 RESPIRATION ABNORMAL 31
874 SCAR 31
875 SENSORY DISTURBANCE 31
876 SUDDEN DEATH 31
877 WAIST CIRCUMFERENCE INCREASED 31
878 WOUND INFECTION PSEUDOMONAS 31
879 APHONIA 30
880 DEVICE POWER SOURCE ISSUE 30
881 DUODENAL ULCER 30
882 EAR PAIN 30
883 GASTROINTESTINAL INFECTION 30
884 INCORRECT PRODUCT ADMINISTRATION DURATION 30
885 MENTAL IMPAIRMENT 30
886 MIDDLE INSOMNIA 30
887 MUSCULOSKELETAL DISORDER 30
888 NEUROGLYCOPENIA 30
889 NEUTROPENIC SEPSIS 30
890 PELVIC FRACTURE 30
891 PEMPHIGOID 30
892 SCLERODERMA 30
893 SCOLIOSIS 30
894 SNORING 30
895 SPRUE-LIKE ENTEROPATHY 30
896 THYROID DISORDER 30
897 URINARY TRACT INFECTION BACTERIAL 30
898 ANAL INCONTINENCE 29
899 ANOREXIA 29
900 ANOSMIA 29
901 BLOOD CREATININE DECREASED 29
902 CHOKING 29
903 DEVICE MAINTENANCE ISSUE 29
904 DILATED CARDIOMYOPATHY 29
905 GLOMERULAR FILTRATION RATE INCREASED 29
906 GLUCOSE TOLERANCE IMPAIRED 29
907 HYDRONEPHROSIS 29
908 HYPERNATRAEMIA 29
909 INCREASED TENDENCY TO BRUISE 29
910 INTERVERTEBRAL DISC SPACE NARROWING 29
911 JOINT STIFFNESS 29
912 KETOACIDOSIS 29
913 LYMPHOPENIA 29
914 ON AND OFF PHENOMENON 29
915 PERSONALITY CHANGE 29
916 PHOTOPHOBIA 29
917 PHOTOSENSITIVITY REACTION 29
918 PRURITUS GENERALISED 29
919 PSORIATIC ARTHROPATHY 29
920 PULSE ABSENT 29
921 STATUS EPILEPTICUS 29
922 THERAPEUTIC PRODUCT EFFECT DECREASED 29
923 VENA CAVA INJURY 29
924 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 29
925 BLOOD CREATININE ABNORMAL 28
926 BLOOD THYROID STIMULATING HORMONE DECREASED 28
927 CARPAL TUNNEL SYNDROME 28
928 DEVICE PHYSICAL PROPERTY ISSUE 28
929 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 28
930 EYE DISORDER 28
931 GYNAECOMASTIA 28
932 HAEMOTHORAX 28
933 HYPOAESTHESIA ORAL 28
934 LOW CARDIAC OUTPUT SYNDROME 28
935 LUMBAR VERTEBRAL FRACTURE 28
936 NERVE INJURY 28
937 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 28
938 PULMONARY HAEMORRHAGE 28
939 RESPIRATORY ARREST 28
940 SCHIZOPHRENIA 28
941 SERUM FERRITIN INCREASED 28
942 SLUGGISHNESS 28
943 STAPHYLOCOCCAL SEPSIS 28
944 STASIS DERMATITIS 28
945 TORTICOLLIS 28
946 VARICES OESOPHAGEAL 28
947 WHITE BLOOD CELLS URINE POSITIVE 28
948 ANAPHYLACTIC SHOCK 27
949 APATHY 27
950 CAROTID ARTERY STENOSIS 27
951 CATHETER SITE ERYTHEMA 27
952 COR PULMONALE 27
953 DRUG TOXICITY 27
954 HAEMOGLOBIN ABNORMAL 27
955 HIGH DENSITY LIPOPROTEIN DECREASED 27
956 HYPOPROTEINAEMIA 27
957 IMPAIRED QUALITY OF LIFE 27
958 INCREASED APPETITE 27
959 INTERVERTEBRAL DISC DISORDER 27
960 INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM 27
961 IRRITABLE BOWEL SYNDROME 27
962 KIDNEY TRANSPLANT REJECTION 27
963 LISTLESS 27
964 MOUTH HAEMORRHAGE 27
965 PROCALCITONIN INCREASED 27
966 PRODUCT LEAKAGE 27
967 PRODUCT PHYSICAL ISSUE 27
968 PRODUCT SUBSTITUTION ISSUE 27
969 RENAL PAIN 27
970 SYNOVIAL CYST 27
971 THERAPY CHANGE 27
972 VAGINAL HAEMORRHAGE 27
973 VASCULAR ANASTOMOTIC HAEMORRHAGE 27
974 VASCULAR COMPRESSION 27
975 ABDOMINAL WALL HAEMORRHAGE 26
976 AMMONIA INCREASED 26
977 BLOOD GLUCOSE FLUCTUATION 26
978 BLOOD PRESSURE INADEQUATELY CONTROLLED 26
979 BRONCHIECTASIS 26
980 CATHETER SITE INFECTION 26
981 COLITIS MICROSCOPIC 26
982 DERMATITIS 26
983 EATING DISORDER 26
984 ERECTILE DYSFUNCTION 26
985 KNEE ARTHROPLASTY 26
986 LARGE INTESTINE PERFORATION 26
987 LUNG INFECTION 26
988 MUSCLE TIGHTNESS 26
989 NECROTISING FASCIITIS 26
990 NORMOCYTIC ANAEMIA 26
991 PRODUCT CONTAMINATION 26
992 PRURITUS GENITAL 26
993 PURULENT DISCHARGE 26
994 UPPER-AIRWAY COUGH SYNDROME 26
995 URINE ODOUR ABNORMAL 26
996 AUTOIMMUNE DISORDER 25
997 AUTOIMMUNE HEPATITIS 25
998 CARDIOVASCULAR INSUFFICIENCY 25
999 CATHETER SITE DISCHARGE 25